Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by bionicjoeon Jan 18, 2019 11:43am
37 Views
Post# 29251492

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The Midas Letter

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The Midas Letter
Auctioneer wrote: It is not the job of management to ensure a continuous run of the stock price.  It ran up nearly 40% in very few days.  The job of management is long-term success of the company. 
Iamsuperss wrote:
bionicjoe wrote: IMO, management dropped the ball in releasing the PR when they did. The sp was on a roll (much to the relief of the retail folks) by Wed and potentially would have hit mid 10's yesterday with an eye on low $11's today if the rally continued. All the momentum was cut short with the PR. No thought given to the retail investor.


it was overbought & was itching for a pullback. The news was a catalyst & accelerated the drop.   As far as I’m concerned this is a good thing & shows confidence from the corporate financing world. I think it will reverse real soon. 




Your percentage gains aren't impressing any longs but might be convincing if you are a day trader.

Management's job is to not only look after shareholder's long term interests but the short and medium terms. Their recent actions have terminated a long sought rally and shareholders are paying the price. They just don't seem to get it. You offer the market more dilution and it will respond with a lower bid on the sp. Why is that so hard to understand? It totally f_cks up a company's ability to gain momentum if you keep releasing news the market sees as negative.
Bullboard Posts